title: Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy.
abstract: BACKGROUND
  The pattern of asthma over the lifespan is different in male and female patients, but etiologic differences according to gender are only partially understood. In women, information regarding factors explaining perimenstrual asthma and the role of hormone-related aspects on asthma-related phenotypes is scanty.
  
  
  OBJECTIVE
  To assess the relationships of eosinophils, IgE, and atopy with (1) asthma according to gender and age of onset and (2) hormone-related events.
  
  
  METHODS
  Using data from the Epidemiological study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness and Atopy, adults and children with asthma recruited in chest clinics (n=313) and first-degree relatives of patients with asthma (n=214) were compared with nonasthmatic controls (n=334) and first-degree relatives without asthma (n=595).
  
  
  RESULTS
  Among asthmatic women, eosinophilia was significantly associated with perimenstrual asthma independently from age, smoking, and asthma severity (eosinophils/mm(3) 330 vs 194; P=.01). In nonasthmatic women, IgE level was significantly decreased (by half) and atopy decreased with menopause, and IgE increased with oral contraceptive use, independently from age and smoking. Considering both genders, the increase of eosinophil counts with asthma was significantly greater in women with childhood-onset asthma than in women with adulthood-onset or in men in general. No interaction between gender and asthma was observed for eosinophils in children and for IgE level and atopy in children and adults.
  
  
  CONCLUSIONS
  Results suggest a role of hormone-related events on asthma-related traits and support the hypothesis of the role of eosinophils in the persistence and severity of asthma.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale U472-IFR69, Epidémiologie et Biostatistique, Villejuif, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Siroux
authors.forename: Florence
authors.initials: F
authors.lastname: Curt
authors.forename: Marie-Pierre
authors.initials: MP
authors.lastname: Oryszczyn
authors.forename: Jean
authors.initials: J
authors.lastname: Maccario
authors.forename: Francine
authors.initials: F
authors.lastname: Kauffmann
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001249:Asthma / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology; D016535:Bronchial Hyperreactivity / Q000453:epidemiology* / Q000235:genetics / Q000276:immunology; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003276:Contraceptives, Oral; D004804:Eosinophils / Q000166:cytology / Q000276:immunology*; D016021:Epidemiologic Studies; D005260:Female; D006728:Hormones; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology / Q000235:genetics / Q000276:immunology; D007073:Immunoglobulin E / Q000097:blood*; D007958:Leukocyte Count; D008297:Male; D008572:Menarche; D008593:Menopause; D012720:Severity of Illness Index; D012737:Sex Factors
chemical_list: D003276:Contraceptives, Oral; D006728:Hormones; D007073:Immunoglobulin E